We are monitoring the impact of COVID-19 on Europe Digital Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date March, 2021
ID: 11328
Share on
Share on

Europe Digital Therapeutics Market Size, Share, Trends and Growth Analysis Report – Segmented By Product, Sales Channel, Application and Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) - Industry Forecast (2021 to 2026)

Pulished: March, 2021
ID: 11328
Pages: 110

Europe Digital Therapeutics Market Size (2021 to 2026)

The Europe Digital Therapeutics Market size was worth USD 612 million in 2020. This value is further forecasted to be growing at a CAGR of 21.4% between 2021 to 2026.

The growing smartphone and internet usage among people and the rising usage of other smart devices in European regions are significant drivers for the digital therapeutic market. Europe spends more than $124 billion a year on the treatment of chronic illness. Digital therapeutics help in diminishing these healthcare costs. Moreover, the increasing prevalence of chronic diseases such as diabetes mainly drives the European Digital Therapeutics Market (DTx). For instance, according to the European Chronic Disease Alliance (ECDA), more than 85% of the deaths were registered in the European Union due to chronic diseases, including cancer, diabetes, chronic respiratory disease, cardiovascular disease, and mental illness. The rise in prevalence of diabetic patients and patients is willing to adapt to different treatment types is boosting the market. Increasing government initiatives for preventive healthcare will further increase awareness among people and promote digital therapeutics. The user-friendliness and patient convenience factor of digital therapeutics are also significant advantages. The technological advancements in mobile healthcare are the key to the growth of the Europe Digital Therapeutics market.

The significant restriction for the digital therapeutics market is the lack of access to digital therapeutics programs in developing countries in Europe. The low awareness among people about these programs' benefits is due to the lack of access to the proper technology is hindering the European Digital Therapeutics Market growth. Moreover, cybersecurity poses a significant threat to databases. The hackers may hack the digital platforms and get all the private data related to the patients. Hence, the security and privacy concerns of the patient's medical data hamper the market growth. Further, the unstable payment models and resistance from traditional healthcare providers will affect market growth negatively during the forecast period. These are the factors that are restraining the European Digital Therapeutics Market.

COVID-19 Impact on Europe Digital Therapeutics Market:

The COVID-19 pandemic had negatively affected the healthcare system in Europe. But the pandemic has positively impacted the global digital therapeutics market and boosted the growth rate. Digital therapeutics help us treat, manage, and monitor the disease at any place without going to hospitals and contacting other people. So even the doctors had started treating their patients using digital applications. The increase in smartphone usage during the pandemic help the market grow during these tough times.

The research report European digital therapeutics market has been segmented and sub-segmented into the following categories.

By Product:

  • Software
  • Device
  • Others

By Sales Channel:

  • B2C
    • Patients
    • Caregivers
  • B2B
    • Providers
    • Payers
    • Employers
    • Pharmaceutical Companies
    • Other Buyers

By Application:

  • Preventive Applications
    • Prediabetes
    • Obesity
    • Nutrition
    • Lifestyle Management
    • Other Preventive Applications
  • Treatment/Care-related Applications
    • Diabetes
    • CNS Disorders
    • Chronic Respiratory Disorders
    • Musculoskeletal Disorders
    • Cardiovascular Diseases
    • Smoking Cessation
    • Medication Adherence
    • Gastrointestinal Disorders
    • Substance Use & Addiction Management
    • Rehabilitation & Patient Care
    • Other Treatment/Care-related Applications

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, the European digital therapeutics market was the second-largest market in 2019 and grow consistently in the near future. The rise in the adoption of smartphones and tablets coupled with healthcare applications in the European region boosts the European Digital Therapeutics Market. For instance, Oxil launched an app in 2017, which is used to tackle mounting cases of obesity, mainly among youth. Some other developers like Azumio provide a fitness buddy mobile app that offers the most prominent exercise database that helps reduce obesity.

The U.K. digital health market is dominating the European Market and is estimated to be in this position throughout the forecast period. The increase in private funding in developing some new applications is boosting the market. Moreover, the rise in adoption and awareness of Digital Therapeutics is propelling the market growth. Further, the increase in the prevalence of diabetes and chronic diseases boosts the European digital therapeutics market's growth. For instance, in 2018, Diabetes is accounted for the highest share and registered a CAGR of 22.6% during the forecast period.


Fitbit, Inc. (Twine Health, Inc.), Medtronic Plc., Novartis International AG (Pear Therapeutics, Inc.), Resmed, Inc. (Propeller Health), Voluntis, Inc., Ada Health GmbH, Cognifit ltd, Caterna Vision GmbH, Sonormed GmbH, and Kaia Health are some of the key companies operating in the European digital health market.

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Product
      1. Software
      2. Device
      3. Others
      4. Y-o-Y Growth Analysis, By Product
      5. Market Attractiveness Analysis, By Product
      6. Market Share Analysis, By Product
    2. By Sales Channel
      1. B2C
        1. Patients
        2. Caregivers
      2. B2B
        1. Providers
        2. Payers
        3. Employers
        4. Pharmaceutical Companies
        5. Other Buyers
      3. Y-o-Y Growth Analysis, By Sales Channel
      4. Market Attractiveness Analysis, By Sales Channel
      5. Market Share Analysis, By Sales Channel
    3. By Application
      1. Preventive Applications
        1. Prediabetes
        2. Obesity
        3. Nutrition
        4. Lifestyle Management
        5. Other Preventive Applications
      2. Treatment/Care-related Applications
        1. Diabetes
        2. CNS Disorders
        3. Chronic Respiratory Disorders
        4. Musculoskeletal Disorders
        5. Cardiovascular Diseases
        6. Smoking Cessation
        7. Medication Adherence
        8. Gastrointestinal Disorders
        9. Substance Use & Addiction Management
        10. Rehabilitation & Patient Care
        11. Other Treatment/Care-related Applications
      3. Y-o-Y Growth Analysis, By Application
      4. Market Attractiveness Analysis, By Application
      5. Market Share Analysis, By Application
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Product
        3. By Technology
        4. By Application
        5. By End-User
      4. Market Attractiveness Analysis      
        1. By Geographical Area
        2. By Product
        3. By Technology
        4. By Application
        5. By End-User
      5.      Market Share Analysis   
        1. By Geographical Area
        2. By Product
        3. By Technology
        4. By Application
        5. By End-User
    2. Europe
      1. Introduction
      2. UK
      3. France
      4. Spain
      5. Germany
      6. Italy
      7. Rest of Europe
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. 2Morrow, Inc.,
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Pear Therapeutics, Inc.
    3. Fitbit, Inc. (Twine Health, Inc.)
    4. Proteus Digital Health, Inc.
    5. Livongo Health, Inc.
    6. Resmed, Inc. (Propeller Health)
    7. Medtronic Plc.
    8. Voluntis, Inc.
    9. Omada Health, Inc.
    10. Welldoc, Inc.
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures  
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • The segment-level analysis in terms of product type along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, essential financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations with a strong financial foothold in the market.

Europe Digital Therapeutics Market

Please wait. . . . Your request is being processed

Related Reports


$ 1234 3335

Click for Request Sample